XML 78 R54.htm IDEA: XBRL DOCUMENT v3.25.0.1
Capital Management (Tables)
 12 Months Ended
Dec. 31, 2024
Corporate information and statement of IFRS compliance [abstract]  
Schedule of total capital
Our capital base presented in the table below consists mainly of common shareholders’ equity, preferred shares and other equity instruments, equity in the participating account, non-controlling interests’ equity, CSM, and certain other capital securities that qualify as regulatory capital.
As at December 31,20242023
Subordinated debt$6,179 $6,178 
Innovative capital instruments(1)
200 200 
Equity:
Preferred shares and other equity instruments2,239 2,239 
Common shareholders’ equity(2)
23,318 21,343 
Equity in the participating account496 457 
Non-controlling interests’ equity76 161 
Contractual Service Margin13,366 11,786 
Total capital(3)
$45,874 $42,364 

(1)    Innovative capital instruments are SLEECS issued by SLCT I (Note 12). SLCT I is not consolidated by us.
(2)    Common shareholders' equity is equal to Total shareholders' equity less Preferred shares and other equity instruments.
(3)    For regulatory reporting purposes under the LICAT framework, there were further adjustments, including goodwill, non-life investments, and others as prescribed by OSFI, to the total capital figure presented in the table above.